Advertisement
Advertisement

STE

STE logo

STERIS plc

237.15
USD
Sponsored
-0.78
-0.33%
Aug 24, 11:32 UTC -4
Open

STERIS plc Profile

About

STERIS plc, develops, manufactures and markets infection prevention, decontamination, microbial reduction, and surgical and gastrointestinal support products and services. On Nov 2, 2015, STERIS completed the acquisition of Synergy Health plc following which it was re-registered under the name ' STERIS plc. Currently, STERIS serves healthcare, pharmaceutical, research, industrial and governmental customers across the globe. The majority of STERIS' revenues is derived from the healthcare and pharmaceutical industries. STERIS provides its products and services in more than 60 countries. The company's key areas of strategic focus include developing its customer base in Europe, the Middle East and the Asia Pacific region.

Info & Links

CEO

Daniel A. Carestio

Headquarters

70 Sir John Rogerson's Quay
Dublin, L2 D02 R296, IRELAND

Industry

Medical Instruments

Sector

Medical

Website

http://www.steris.com

Auditor

Ernst & Young LLP

Share holders

360

Employees

17,937

STERIS plc Statistics

Valuation Measures

Market Capitalization2

23.12B

Enterprise Value

24.53B

Enterprise Value/EBITDA(ttm)

15.03

Price to Earnings Ratio(ttm)

22.83

Price to Sales(ttm)

3.84

Price to Book(mrq)

3.21

Price to Cash(ytd)

15.66

Profitability

Gross Margin(ttm)

44.44%

Operating Margin(ttm)

16.99%

Profit Margin(ttm)

13.32%

Return on Equity(ttm)

14.34%

Return on Invested Capital(ttm)

9.01%

Return on Assets(ttm)

9.66%

Income Statement

Revenue(ttm)

6.04B

Revenue Per Share(ttm)

61.92

Gross Profit(ttm)

2.68B

EBITDA(ttm)3

1.63B

Net Income Available to Common(ttm)

805.00M

Diluted EPS(ttm)

8.18

Share Statistics

Beta (5Y Monthly)

0.91

52-Week Change

-5.84%

S&P 500 52-Week Change

18.55%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

97.50M

Dividend Yield

1.06%

Float4

96.41M

% Held by Insiders

1.12%

% Held by Institutions

94.69%

Balance Sheet

Total Cash(mrq)

482.30M

Total Cash Per Share(mrq)

4.95

Total Debt(mrq)

1.89B

Total Debt/Equity(mrq)

26.22%

Current Ratio(mrq)

1.91%

Quick Ratio(mrq)

1.35%

Book Value Per Share(mrq)

74.06

Cash Flow

Operating Cash Flow Per Share(ytd)

3.75

Free Cash Flow(ytd)

279.60M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement